DoD Neurofibromatosis New Investigator Award

The summary for the DoD Neurofibromatosis New Investigator Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Neurofibromatosis New Investigator Award: The intent of the NFRP New Investigator Award is to support the continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in the field of NF research. Prior experience in NF research is not required. However, Principal Investigators (PIs) with a limited background in NF research are strongly encouraged to have a collaborator who is experienced in the NF field.

Research projects may focus on any phase of research, excluding clinical trials. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.

Preclinical Research: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. For projects involving animal studies, applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at
http://www.elsevier.com/__data/promis_misc/622936arrive_ guidelines.pdf.
Federal Grant Title: DoD Neurofibromatosis New Investigator Award
Federal Agency Name: Dept of the Army USAMRAA
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-16-NFRP-NIA
Type of Funding: Cooperative Agreement, Grant
CFDA Numbers: 322137
CFDA Descriptions: Military Medical Research and Development
Current Application Deadline: Aug 1, 2016
Original Application Deadline: Aug 1, 2016
Posted Date: May 9, 2016
Creation Date: May 9, 2016
Archive Date: Aug 31, 2016
Total Program Funding: $2,880,000
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Help Desk Phone: 301-682-5507 Email: [email protected]
CDMRP Help Desk

Dept. of the Army -- USAMRAA 301-619-7144